Latest news from Biotech, Pharma, Medtech & Digital Health

Fraunhofer ITMP uses high-tech methods for cell-based drug screening. (Picture: ©Fraunhofer ITMP)

28.06.2021 Stem Cell-Based Translation

The North as a hub for global stem cell research: The 2021 Annual Meeting of the International Society for Stem Cell Research (ISSCR) was scheduled ...

In addition to climate protection, funding schemes in Hamburg should also find their way into the fields of life science, infection and pandemic control, and digitalization. (Picture: ©Mediaserver Hamburg/Timo Sommer)

28.06.2021 EUR 30 million in EU funds for projects in Hamburg

The European Commission has approved the use of EUR 30 million in funds for climate protection and innovation funds in Hamburg through 2023 as part ...

Dr. Tanmay Bharat, Sir William Dunn School of Pathology, University of Oxford (Picture: ©Eppendorf AG)

25.06.2021 Eppendorf Award for Young European Investigators 2021

In 2021, Eppendorf AG, the Hamburg life sciences company, is presenting its highly prestigious research prize for the 26th time. The independent ...

May 26, 2021, is the effective date of the new EU regulation, which came into force four years ago. (Picture: ©Miriam Barton)

25.06.2021 How to master the MDR challenge

How medical technology companies in the North succeed to deal with the new requirements of the Medical Device Regulation – even in uncertain times and ...

18.06.2021 Sysmex supports healthcare workers in fighting the pandemic

Sysmex Europe GmbH announces the launch of the HISCL™-5000 fully automated random-access immunochemistry analyser and the HISCL™ SARS-CoV-2 Ag Assay Kit ...

17.06.2021 Sysmex obtains the first IVDR certification

Sysmex Europe GmbH announced that LYNOAMP CK19 E [1], part of OSNATM [2] method using a molecular biological technique for cancer ...

Indivumed is using nRavel™ for target discovery and drug development programs. (Picture: ©Jackie Niam/stock.adobe.com)

03.06.2021 Indivumed Launches the nRavel AI Platform

Indivumed GmbH (“Indivumed”) today announced the launch of nRavel™, a unique AI discovery platform for oncology and precision medicine. The platform combines ...

New Entity to Develop Therapeutics Targeting RAS Pathway Mutations in Colorectal Cancer (Picture: © Indivumed GmbH)

20.05.2021 Indivumed Joins KHR Biotech

Indivumed GmbH (“Indivumed”) CEO Dr. Hartmut Juhl and University Medical Center Mainz Professor Krishnaraj Rajalingam today announced Indivumed will be joining the newly formed KHR ...

Zanadio is available as an app for iOS and Android and accompanies people with obesity in the areas of exercise, nutrition and behavior change. (Picture: ©aidhere GmbH)

19.05.2021 App-based obesity therapy

Among the first digital health applications reimbursed by the German standard care system is an app-based therapy developed by aidhere GmbH. The ...

Richter-Helm BioLogics Groundbreaking Management © Richter-Helm BioLogics GmbH & Co. KG

12.05.2021 German CDMO Richter-Helm Triples cGMP Production

a leading Germany-based, cGMP compliant biopharmaceutical Contract Development and Manufacturing Organization (CDMO) announced today the start of construction for an expansion project at its cGMP ...